SNWV · SANUWAVE Health, Inc.
$6.38
+0.02 (+0.31%)
At close · Jul 29
Market Cap
$54.69M
Shares
8.60M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.38
Open$6.28
Day$6.28–6.66
52W$5.77–46.59
Avg vol 30d319K
Short int615K · 7.2% float · 1.9d
Short vol43%
Last earningsMar 26, 2026
DataOct 2024–Jul 2026
Filing10-Q · May 12
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−71%
below
Price vs 50-day avg
−44%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−36%
trailing
6-month return
−75%
trailing
YTD return
−79%
this year
Relative strength
−82%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $22 — 200d above 50d
Institutional flow
Distributing
13 of 62 funds reported for Jun 30 · net -12.6K sh shares · +1 new
Insider flow
Distributing
Net -$170.5K over 90 days · 100% sells
Short interest
Falling
7.15% of float · ▼ -2.5% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
62 holders — near 1-yr high, broad support
Squeeze score
59
elevated · 0–100
Fundamentals
Revenue growth
+35%
Y/Y
Gross margin
77%
expanding
EPS growth
+106%
Y/Y
Free cash flow
$1.9M
Valuation
P/E 6.6
below peers
Balance sheet
$9.9M
net debt
Quant / Vol
risk profile
Volatility
94%
annualized · 1-yr
Max drawdown
−87%
past year
ATR
15.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 12, 2026
Revenue growth
· Q2 2026
Initiated
10% – 15%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−71%
Bearish
Price vs 50-day avg
−44%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $11 › 200d $22 — 200d above 50d
Institutional flow
Distributing
13 of 62 funds reported for Jun 30 · net -12.6K sh shares · +1 new
Insider flow
Distributing
Net -$170.5K over 90 days · 100% sells
Short interest
Falling
7.15% of float · ▼ -2.5% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
62 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $6
Now $6 · 1%
52-wk high $47
vs 200-day avg -71%
vs 50-day avg -44%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross margin | 77.3% | Q1 2026 | — |
| Ultramist® consumables revenue | $6.7M | Q1 2026 | — |
|
|
|||
| Ultramist® systems sold | 97 | Q1 2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SNWV
this stock
SANUWAVE Health, Inc.
|
$54.69M | -78.6% | +35.0% | 6.6 | 7.2% |
|
ABT
Abbott Laboratories
|
$186.84B | -13.4% | +5.7% | 30.1 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | +0.5% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.1% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SNWV | +7.2% | -36.2% | -75.2% | -36.2% | -78.6% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | +9.6% | -33.9% | -81.6% | -33.9% | -85.6% |